Back

GRI Bio presents Phase 2a data on GRI-0621 at ERS 2026

Verifying
  • GRI Bio presented new Phase 2a data for GRI-0621 at ERS 2026.
  • The presentation examined GRI-0621 across nine mechanistic pillars.
  • The data focused on the candidate’s mechanism of action in IPF.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.